AR and urinary bladder carcinoma: Treatment with N-butyl-N-(4-hydroxybutyl) nitrosamine caused the development of bladder cancer in more than 92% of wildtype male mice and 42% of wildtype female mice, whereas no AR knockout mice developed bladder cancer48.